Based on mucosal immunization to promote both mucosal and systemic immune responses,
next-generation coronavirus disease 2019 (COVID-19) vaccines would be administered …

Although COVID-19 has captured most of the public health attention, antimicrobial
resistance (AMR) has not disappeared. To prevent the escape of resistant microorganisms …

SARS-CoV-2 is an emerging infectious disease of zoonotic origin that caused the
coronavirus disease in late 2019 and triggered a pandemic that has severely affected …

Vaccine effectiveness (VE) and the urgency of booster vaccination against SARS-CoV-2
Omicron variant need evaluation. A systematic search was conducted from 1–6 April, 2022 …

The quality of asymptomatic corona virus disease 2019 (COVID-19) computed tomography
(CT) image is reduced due to interference from Gaussian noise, which affects the …

Zika virus (ZIKV) is a mosquito-borne flavivirus with maternal infection associated with
preterm birth, congenital malformations, and fetal death, and adult infection associated with …

As of March 2020, the time when the coronavirus disease 2019 (COVID-19) caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a pandemic, our …

The vertebrate immune system is capable of strong, focused adaptive responses that
depend on T-cell specificity in recognizing antigenic sequences of a pathogen. Recognition …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for a
pandemic that has, thus far, caused over 400 million cases of coronavirus disease-19 …

Low-cost and affordable vaccines and biotherapeutics will allow for more equitable global
distribution and improve population coverage, especially in low-and middle-income …